Roswell Park Leukemia Expert Led ASH 2025 Studies Assessing 2 New Treatment Strategies for Advanced AML

Chief of Leukemia at Roswell Park to present studies on crenolanib and ziftomenib at the American Society of Hematology annual meeting.